CompletedNot Applicable

Andosan in Allergic and Asthma Patients

Norway34 participantsStarted 2021-08-31

Plain-language summary

Examine whether daily oral ingestion of a immunomodulatory mushroom extract (AndoSanTM) in patients with asthma and allergy, undergoing allergen specific immunotherapy experience clinical and biochemical improvement in their disease. A prospective randomised study comparing the mushroom extract with placebo.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Asthma or allergy patients that are eligible for ASIT (Allergen specific immunotherapy). * Age above 18. * Able to understand written and oral Norwegian Exclusion Criteria: \- none other than not meeting the inclusion criteria

What they're measuring

FEV1

Timeframe: 20 days

Trial details

NCT IDNCT05192720

SponsorUniversity Hospital, Akershus

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Allergic Asthma trials